We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Gallstone Surgery Has No Downside

By HospiMedica International staff writers
Posted on 07 Aug 2012
The common practice of delaying laparoscopic cholecystectomy (LC) in patients with gallstone pancreatitis until laboratory values stabilize lengthens hospital stay without benefit to patients, according to a new study.

Researchers at the Olive View-UCLA Medical Center (Sylmar, CA, USA) conducted a retrospective review involving 303 patients with mild gallstone pancreatitis, of whom 117 underwent an early LC and 186 underwent a delayed LC. More...
For those who had surgery more than 48 hours after admission, the most common reason for the delay was waiting for normalization of bilirubin or pancreatic enzyme levels, secondary to surgeon preference. The main outcome measures were hospital length of stay, morbidity and mortality rates, and the use of endoscopic retrograde cholangiopancreatography (ERCP).

The results showed that similar hospital admission variables were observed in the early and delayed LC groups, although the delayed group was older. The median hospital length of stay was significantly less for the early group (three days) than for the delayed group (six days). There were no patients who died, and the complication rates were similar for both groups. However, the patients who underwent an early LC were less likely than patients who underwent a delayed LC to undergo ERCP (16% versus 27%, respectively), usually performed for persistent elevation of the total bilirubin level or a dilated common bile duct. The study was published early online on July 16, 2012, in Archives of Surgery.

“We believe that the safety of an early laparoscopic cholecystectomy lies in the identification and exclusion of patients who may be at risk of progressing to a more severe pancreatitis, such as those with tachycardia, elevated serum urea nitrogen level, or evidence of cholangitis at hospital admission,” concluded lead author Darin Saltzman, MD, PhD, and colleagues of the departments of medicine and emergency medicine. “The practice of delaying a laparoscopic cholecystectomy until normalization of laboratory values appears to be unnecessary; it's time for a paradigm shift.”

Acute biliary pancreatitis is a common clinical scenario encountered by the general surgeon. The etiology can be explained by the “common channel” theory, in which the ampulla of Vater is transiently obstructed by a gallstone, leading to pancreatic inflammation and autodigestion. Since most of the offending stones are passed into the feces, the ensuing pancreatitis is generally mild and can often be managed supportively. To prevent further episodes, elective LC is routinely performed during the same hospital admission to remove the source of calculi.

Related Links:

Olive View-UCLA Medical Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.